LSVT LOUD outperforms NHS speech and language therapy for people with Parkinson’s disease

FHS
July 11, 2024
5:30 pm

An intensive voice treatment developed in the USA and known as the Lee Silverman voice treatment (LSVT LOUD) is more effective than conventional NHS speech and language therapy or no therapy for people with Parkinson’s disease, finds a trial published in The BMJ today.

Ozempic Price Cut; Hypoparathyroidism Tx Fast Tracked; Halle Berry’s Menopause Bill

Novo Nordisk cut the price of its blockbuster weight-loss and diabetes drug semaglutide (Wegovy, Ozempic). (Reuters) In adults with increased fracture risk, once-weekly 1-mg semaglutide

May 8, 2024

Early life food allergy associated with increased risk of asthma and reduced lung growth

Having a food allergy as a baby is linked to asthma and reduced lung function later in childhood, according to a world first study.

July 25, 2023

Apellis expects EU to reject eye drug; Terray teams up with Bristol Myers; Vandria raises $20M

Plus, news on Inductive Bio, AbelZeta Pharma, GPCR Therapeutics, Bridge Biotherapeutics and NextCure. Apellis preempts EU rejection for eye drug: The company expects a negative

December 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.